Literature DB >> 23121837

One-year clinical prediction in Chinese ischemic stroke patients using the CHADS2 and CHA2DS2-VASc scores: the China National Stroke Registry.

Shu-Ya Li1, Xing-Quan Zhao, Chun-Xue Wang, Li-Ping Liu, Gai-Fen Liu, Yi-Long Wang, Yong-Jun Wang.   

Abstract

AIMS: We investigated whether CHADS2 or CHA2DS2-VASc scores could be used to predict 1-year prognosis in stroke recurrence, mortality, and mortality of ischemic stroke or transient ischemic attack (TIA) patients with nonvalvular atrial fibrillation (NVAF).
METHODS: Patients were selected from a national prospective registry in China. The clinical prediction of the scores was examined using the C statistic. Univariate and multivariate logistic regressions were performed to analyze the relevant risk factors.
RESULTS: Thousand two hundred and ninety-seven of 22,216 patients were enrolled in the study. For stroke recurrence rate, the C statistic value was 0.53 (odds ratio [OR] 1.15, 95% confidence interval [CI]: 1.01 to 1.32) for CHADS2 and 0.55 (OR 1.14, 95% CI: 1.05 to 1.24) for CHA2DS2-VASc; adding baseline National Institutes of Health Stroke Scale (NIHSS) score to these two scores, the value of C statistic was 0.58 (OR 1.25 95% CI: 1.14 to 1.37) and 0.58 (OR 1.19, 95% CI: 1.11 to 1.27), respectively.
CONCLUSIONS: Both CHADS2 and CHA2DS2-VASc scores have limitations in predicting the 1-year prognosis of stroke/TIA patients with NVAF in China. The predictive value of these two scores improved by adding the baseline NIHSS score.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121837      PMCID: PMC6493534          DOI: 10.1111/cns.12021

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  11 in total

Review 1.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

2.  Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China.

Authors:  Xiaomeng Yang; Shuya Li; Xingquan Zhao; Liping Liu; Yong Jiang; Zixiao Li; Yilong Wang; Yongjun Wang
Journal:  BMC Neurol       Date:  2017-12-04       Impact factor: 2.474

3.  Ethnicity and anticoagulation management of hospitalized patients with atrial fibrillation in northwest China.

Authors:  Xinchun Cheng; Xianhui Zhou; Shifei Song; Min Wu; Roza Baolatejiang; Yanmei Lu; Yaodong Li; Wenhui Zhang; Wenkui Lv; Yuanzheng Ye; Qina Zhou; Hongli Wang; Jianghua Zhang; Qiang Xing; Baopeng Tang
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

Review 4.  Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Authors:  Ayrton R Massaro; Gregory Y H Lip
Journal:  Arq Bras Cardiol       Date:  2016-08-11       Impact factor: 2.000

5.  Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai.

Authors:  Feng-Di Liu; Rong Zhao; Xue-Mei Wang; Shuo Wang; Xiao-Lei Shen; Xiao-Xiao Tao; Bo Zheng; Jia-Li Peng; Hui Zhang; Ran Mo; Yan Tong; Wen-Ting Li; Xiao-Yan Feng; Ge-Fei Li; Liang Shu; Jian-Ren Liu
Journal:  Chronic Dis Transl Med       Date:  2016-01-08

6.  Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.

Authors:  Changsheng Ma; Lionel Riou França; Shihai Lu; Hans-Christoph Diener; Sergio J Dubner; Jonathan L Halperin; Qiang Li; Miney Paquette; Christine Teutsch; Menno V Huisman; Gregory Y H Lip; Kenneth J Rothman
Journal:  J Arrhythm       Date:  2020-03-10

7.  Factors for short-term outcomes in patients with a minor stroke: results from China National Stroke Registry.

Authors:  Lingyun Wu; Anxin Wang; Xianwei Wang; Xingquan Zhao; Chunxue Wang; Liping Liu; Huaguang Zheng; Yongjun Wang; Yibin Cao; Yilong Wang
Journal:  BMC Neurol       Date:  2015-12-09       Impact factor: 2.474

Review 8.  Atrial fibrillation.

Authors:  Thomas M Munger; Li-Qun Wu; Win K Shen
Journal:  J Biomed Res       Date:  2013-12-28

9.  Continuation of dabigatran therapy in "real-world" practice in Hong Kong.

Authors:  Mei Han Ho; Chi Wai Ho; Emmanuel Cheung; Pak Hei Chan; Jo Jo Hai; Koon Ho Chan; Esther W Chan; Gilberto Ka Kit Leung; Hung Fat Tse; Chung Wah Siu
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Authors:  Chern-En Chiang; Ken Okumura; Shu Zhang; Tze-Fan Chao; Chung-Wah Siu; Toon Wei Lim; Anil Saxena; Yoshihide Takahashi; Wee Siong Teo
Journal:  J Arrhythm       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.